CD27 and neoplasm: Moreover, conditioning treatment with CD27 mAb in a preclinical model enhanced the expansion and anti-tumor activity of adoptively transferred T cells (53) and by activating T cells recruits and stimulates myeloid cells for enhanced killing of CD27 mAb-opsonized tumors (54).